NEK2 amplification as a biomarker of poor prognosis across multiple cancers

Huerxidan Abudumijiti1,2,3, Xin Ran2, Sanqian Huang4

  • 1State Key Laboratory of Experimental Hematology, Bioinformatics Center, National Clinical Research Center for Geriatric Disorders, Key Laboratory for Carcinogenesis and Invasion, Chinese Ministry of Education, Key Laboratory of Carcinogenesis, Chinese Ministry of Health, Furong Laboratory, Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan 410078, China.

Abstract

No abstract available in PubMed .